COM:IMMUNOCORE
Immunocore Holdings plc
- Stock
Last Close
32.12
22/11 21:00
Market Cap
1.90B
Beta: -
Volume Today
190.00K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | -3.78M - | 471.50K - | 2.72M 477.31% | ||||
average payables | 11.09M - | 10.76M 2.98% | 20.61M 91.61% | 55.26M 168.11% | 46.44M 15.96% | ||
average receivables | 48.06M - | 36.63M 23.78% | 24.03M 34.41% | 41.62M 73.22% | 55.25M 32.74% | ||
book value per share | 0.00 - | 0.00 73.89% | 1.74 321,825.95% | 3.91 124.59% | 6.10 55.91% | 0.01 99.88% | |
capex per share | -0.00 - | -0.00 20.89% | -0.10 61,665.48% | -0.02 76.24% | -0.05 109.13% | ||
capex to depreciation | -0.53 - | -0.46 11.99% | -0.34 26.21% | -0.14 58.02% | -0.36 149.28% | ||
capex to operating cash flow | 0.21 - | 0.04 80.17% | 0.05 20.31% | 0.01 84.69% | 0.07 804.40% | ||
capex to revenue | -0.15 - | -0.17 11.40% | -0.10 38.72% | -0.04 62.76% | -0.02 59.79% | ||
cash per share | 0.00 - | 0.00 40.53% | 4.08 150,574.95% | 5.42 32.88% | 7.27 34.13% | 0.01 99.88% | |
days of inventory on hand | 758.14 - | 1.58K 108.97% | |||||
days payables outstanding | 60.36K - | 6.26K 89.62% | |||||
days sales outstanding | 711.00 - | 711.67 0.09% | 281.38 60.46% | 341.88 21.50% | 148.30 56.62% | 76.23 48.60% | |
debt to assets | 0.10 - | 0.32 231.86% | 0.32 1.25% | 0.21 34.71% | 0.16 24.78% | 0.06 62.08% | |
debt to equity | 0.33 - | 4.02 1,105.45% | 1.15 71.30% | 0.37 67.76% | 0.25 33.19% | 0.10 60.72% | |
dividend yield | |||||||
earnings yield | -0.00 - | -0.00 50.49% | -0.07 63,108.61% | -0.12 60.71% | -0.02 83.83% | -0.00 99.91% | |
enterprise value | 926.22B - | 893.09B 3.58% | 941.47M 99.89% | 938.58M 0.31% | 1.89B 101.70% | 3.34T 176,313.74% | |
enterprise value over ebitda | -11.44K - | -8.29K 27.54% | -12.48 99.85% | -6.95 44.33% | -51.93 647.61% | -55.99K 107,710.86% | |
ev to operating cash flow | -55.71K - | -8.81K 84.19% | -15.54 99.82% | -7.23 53.46% | -60.54 736.94% | 1.14M 1,876,386.13% | |
ev to sales | 39.16K - | 34.79K 11.15% | 31.26 99.91% | 35.39 13.20% | 13.17 62.79% | 13.39K 101,561.33% | |
free cash flow per share | -0.00 - | -0.00 423.99% | -2.00 51,659.10% | -2.98 48.86% | -0.73 75.44% | 0.00 100.01% | |
free cash flow yield | -0.00 - | -0.00 443.48% | -0.06 53,313.52% | -0.12 85.99% | -0.02 86.79% | 0.00 100.01% | |
graham net net | 0.00 - | -0.00 471.91% | 0.17 7,739.17% | 2.88 1,633.38% | 4.81 67.18% | 0.01 99.89% | |
graham number | 0.01 - | 0.01 38.46% | 9.56 140,321.58% | 16.24 69.96% | 11.12 31.52% | 0.01 99.88% | |
income quality | 0.23 - | 0.98 320.24% | 0.82 16.19% | 0.99 20.67% | 0.76 23.11% | ||
intangibles to total assets | 0.00 - | 0 100% | 0 | 0 | 0.00 Infinity% | 0 100% | |
interest coverage | -110.99 - | -31.17 71.92% | -27.72 11.06% | -23.25 16.13% | -5.15 77.85% | 11.57 324.76% | |
interest debt per share | 0.00 - | 0.00 220.50% | 2.11 90,973.25% | 1.59 24.67% | 1.68 6.07% | 0.00 99.96% | |
inventory turnover | 0.48 - | 0.23 52.15% | |||||
invested capital | 0.33 - | 4.02 1,105.45% | 1.15 71.30% | 0.37 67.76% | 0.25 33.19% | 0.10 60.72% | |
market cap | 926.33B - | 893.11B 3.59% | 1.01B 99.89% | 1.11B 10.46% | 2.16B 93.81% | 3.34T 154,796.78% | |
net current asset value | 31.99M - | -46.60M 245.68% | 11.08M 123.78% | 132.50M 1,095.52% | 235.12M 77.45% | 300.66M 27.88% | |
net debt to ebitda | 1.30 - | 0.14 89.63% | 0.87 545.53% | 1.29 47.64% | 7.22 460.59% | 6.82 5.60% | |
net income per share | -0.00 - | -0.00 45.09% | -2.33 61,150.79% | -3.00 28.62% | -0.90 69.93% | -0.00 99.87% | |
operating cash flow per share | -0.00 - | -0.00 509.74% | -1.91 51,237.03% | -2.96 55.21% | -0.68 76.88% | 0.00 100.01% | |
payables turnover | 0.01 - | 0.06 863.50% | |||||
receivables turnover | 0.51 - | 0.51 0.09% | 1.30 152.92% | 1.07 17.70% | 2.46 130.54% | 4.79 94.54% | |
research and ddevelopement to revenue | 3.53 - | 3.90 10.25% | 2.48 36.23% | 2.76 11.15% | 0.62 77.53% | 0.66 5.69% | |
return on tangible assets | -0.37 - | -0.56 52.76% | -0.38 32.88% | -0.44 15.99% | -0.09 78.26% | -0.09 2.25% | |
revenue per share | 0.00 - | 0.00 8.52% | 0.95 100,695.03% | 0.60 36.19% | 3.14 420.04% | 0.01 99.84% | |
roe | -1.27 - | -7.04 455.80% | -1.34 80.97% | -0.77 42.73% | -0.15 80.71% | -0.15 1.36% | |
roic | -1.01 - | -0.85 15.35% | -0.50 41.39% | -0.48 3.54% | -0.10 79.67% | -0.15 50.94% | |
sales general and administrative to revenue | 1.44 - | 1.72 19.20% | 1.52 11.76% | 3.33 119.46% | |||
shareholders equity per share | 0.00 - | 0.00 73.89% | 1.74 321,825.95% | 3.91 124.59% | 6.10 55.91% | 0.01 99.88% | |
stock based compensation to revenue | 0.03 - | 0.12 322.84% | 0.27 127.66% | 1.35 398.91% | 0.19 86.08% | ||
tangible asset value | 56.26M - | 14.77M 73.75% | 55.35M 274.69% | 171.55M 209.95% | 278.35M 62.26% | 368.84M 32.51% | |
tangible book value per share | 0.00 - | 0.00 73.75% | 1.74 321,825.95% | 3.91 124.59% | 6.09 55.68% | 0.01 99.88% | |
working capital | 121.57M - | 39.77M 67.29% | 97.93M 146.26% | 201.55M 105.80% | 308.79M 53.21% | 389.80M 26.23% |
All numbers in USD (except ratios and percentages)